BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14636827)

  • 21. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX; Niu ZY; Zhao SL; Smith AJ
    Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
    Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
    Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
    J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta 1 enhances the generation of allospecific cytotoxic T lymphocytes.
    Kondo S; Isobe K; Ishiguro N; Nakashima I; Miura T
    Immunology; 1993 Jul; 79(3):459-64. PubMed ID: 8406573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of IL-4, TGF-beta and LPS in IgA switching.
    Kunimoto DY; Ritzel M; Tsang M
    Eur Cytokine Netw; 1992; 3(4):407-15. PubMed ID: 1421013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter.
    Shi MJ; Stavnezer J
    J Immunol; 1998 Dec; 161(12):6751-60. PubMed ID: 9862705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid induces the expression of germ-line C alpha transcript mainly by a TGF-beta-independent mechanism.
    Tokuyama H; Tokuyama Y
    Cell Immunol; 1997 Feb; 176(1):14-21. PubMed ID: 9070313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
    Jinnin M; Ihn H; Tamaki K
    Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression.
    Tan NS; Michalik L; Di-Poï N; Ng CY; Mermod N; Roberts AB; Desvergne B; Wahli W
    EMBO J; 2004 Oct; 23(21):4211-21. PubMed ID: 15470497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
    Huber D; Philipp J; Fontana A
    J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of immune response by bacterial lipopolysaccharide (LPS): cellular basis of stimulatory and inhibitory effects of LPS on the in vitro IgM antibody response to a T-dependent antigen.
    Uchiyama T; Jacobs DM
    J Immunol; 1978 Dec; 121(6):2347-51. PubMed ID: 309900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement for Runx proteins in IgA class switching acting downstream of TGF-beta 1 and retinoic acid signaling.
    Watanabe K; Sugai M; Nambu Y; Osato M; Hayashi T; Kawaguchi M; Komori T; Ito Y; Shimizu A
    J Immunol; 2010 Mar; 184(6):2785-92. PubMed ID: 20142360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of transforming growth factor beta on immunoglobulin production in cultured rat lacrimal gland tissue fragments.
    Rafferty DE; Montgomery PC
    Reg Immunol; 1993; 5(6):312-6. PubMed ID: 8068533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoids enhance IgA production by lipopolysaccharide-stimulated murine spleen cells.
    Tokuyama H; Tokuyama Y
    Cell Immunol; 1993 Sep; 150(2):353-63. PubMed ID: 8370078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.